National Bank of Canada FI Has $6.15 Million Position in DaVita Inc. (NYSE:DVA)

National Bank of Canada FI grew its position in shares of DaVita Inc. (NYSE:DVA - Free Report) by 7.6% in the fourth quarter, according to the company in its most recent 13F filing with the Securities & Exchange Commission. The fund owned 41,125 shares of the company's stock after acquiring an additional 2,893 shares during the quarter. National Bank of Canada FI owned 0.05% of DaVita worth $6,150,000 at the end of the most recent reporting period.

Several other hedge funds also recently made changes to their positions in the business. SBI Securities Co. Ltd. bought a new position in DaVita in the fourth quarter valued at $41,000. Quarry LP acquired a new position in shares of DaVita during the 3rd quarter worth about $60,000. Venturi Wealth Management LLC grew its holdings in shares of DaVita by 59.8% in the 4th quarter. Venturi Wealth Management LLC now owns 406 shares of the company's stock valued at $61,000 after acquiring an additional 152 shares in the last quarter. Versant Capital Management Inc increased its position in shares of DaVita by 58.7% in the fourth quarter. Versant Capital Management Inc now owns 457 shares of the company's stock valued at $68,000 after acquiring an additional 169 shares during the last quarter. Finally, Blue Trust Inc. raised its holdings in DaVita by 39.7% during the fourth quarter. Blue Trust Inc. now owns 461 shares of the company's stock worth $76,000 after acquiring an additional 131 shares in the last quarter. 90.12% of the stock is owned by institutional investors.

DaVita Stock Performance

DVA stock traded up $2.12 during mid-day trading on Friday, hitting $155.48. 581,032 shares of the company were exchanged, compared to its average volume of 822,267. The stock has a market capitalization of $12.44 billion, a PE ratio of 14.48, a price-to-earnings-growth ratio of 1.07 and a beta of 1.04. The business has a 50 day simple moving average of $152.13 and a 200-day simple moving average of $156.63. The company has a current ratio of 1.26, a quick ratio of 1.21 and a debt-to-equity ratio of 23.18. DaVita Inc. has a 1-year low of $125.64 and a 1-year high of $179.60.

DaVita (NYSE:DVA - Get Free Report) last posted its quarterly earnings data on Thursday, February 13th. The company reported $2.24 earnings per share for the quarter, topping the consensus estimate of $2.14 by $0.10. DaVita had a return on equity of 115.48% and a net margin of 7.31%. On average, equities analysts forecast that DaVita Inc. will post 10.76 earnings per share for the current year.

Analysts Set New Price Targets

Several equities research analysts have recently commented on the company. Barclays increased their price objective on DaVita from $164.00 to $169.00 and gave the company an "equal weight" rating in a report on Tuesday, February 18th. StockNews.com upgraded shares of DaVita from a "hold" rating to a "buy" rating in a research note on Thursday. Cowen reissued a "hold" rating on shares of DaVita in a research report on Tuesday, February 18th. Finally, Sanford C. Bernstein set a $184.00 price objective on DaVita in a research report on Friday, February 21st. One research analyst has rated the stock with a sell rating, four have assigned a hold rating and two have assigned a buy rating to the stock. According to MarketBeat, the stock presently has an average rating of "Hold" and a consensus target price of $166.33.

About DaVita

DaVita Inc provides kidney dialysis services for patients suffering from chronic kidney failure in the United States. The company operates kidney dialysis centers and provides related lab services in outpatient dialysis centers. It also offers outpatient, hospital inpatient, and home-based hemodialysis services; operates clinical laboratories that provide routine laboratory tests for dialysis and other physician-prescribed laboratory tests for ESRD patients; and management and administrative services to outpatient dialysis centers.